Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 483 of 1,261

  1. US 10370430

    Recombinant factor VIII proteins

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  2. US 10370380

    Octahydropyrrolo[3,4-c]pyrrole derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  3. US 10370371

    Substituted pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  4. US 10370367

    IRAK inhibitors and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  5. US 10370419

    Tuberculosis vaccine compositions and related methods

    THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXTAS SYSTEM · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  6. US 10370357

    Method for producing sulfonyl chloride compound

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  7. EP 3515433

    DIE BLUT-HIRN-SCHRANKE PASSIERENDE DOPAMIN-B-HYDROXYLASE-INHIBITOREN

    BIAL PORTELA & Cª S A [PT] · Granted Jul 31, 2019 · Expires Jul 26, 2039

    granted

  8. US 10363292

    Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  9. US 10363288

    Insulin mimotopes and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  10. US 10363248

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  11. US 10363246

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  12. US 10363241

    Substituted imidazole derivatives and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  13. US 10363294

    Yeast-brachyury immunotherapeutic compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  14. US 10363289

    Mutant OPAA enzyme with increased catalytic efficiency on GP

    The United States of America as represented by the Secretary of the Army · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  15. US 10363301

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  16. US 10364233

    Piperidine derivative and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  17. US 10364295

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  18. US 10364473

    Fast diagnosis and personalized treatments for acne

    The Regents of the University of California · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  19. US 10363312

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  20. US 10363311

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  21. US 10363286

    Peptide inhibition of CCR3-mediated diseases or conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  22. US 10363319

    Glycoconjugates and methods for their use

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  23. US 10364227

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  24. US 10363232

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.